Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
종목 코드 ALUR
회사 이름Allurion Technologies Inc
상장일Mar 29, 2021
CEOGaur (Shantanu)
직원 수134
유형Ordinary Share
회계 연도 종료Mar 29
주소11 Huron Dr Ste 200
도시NATICK
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호01760
전화15086474000
웹사이트https://www.allurion.com/en
종목 코드 ALUR
상장일Mar 29, 2021
CEOGaur (Shantanu)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음